British biotech investment remains strong despite Brexit

A report from the UK BioIndustry Association (BIA) and Informa Pharma Intelligence reveals robust levels of investment in the UK biotech sector, indicating that companies raised £1.3 billion ($1.7 billion) in 2019.

This amount breaks down to £679 million from venture capital, £64 million from initial public offerings (IPOs) and £596 million from other public financing rounds.

This represents the third highest level recorded by the trade association, and shows that since the year 2012, investment has increased fourfold.